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Morphometric Evidence for Neuronal and Glial
Prefrontal Cell Pathology in Major Depression*
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Stephen D. Pittman, Herbert Y. Meltzer, James C. Overholser, Bryan L. Roth, and
Craig A. Stockmeier
Background: This report provides histopathological evi-
dence to support prior neuroimaging findings of de-
creased volume and altered metabolism in the frontal
cortex in major depressive disorder.
Methods: Computer-assisted three-dimensional cell
counting was used to reveal abnormal cytoarchitecture in
left rostral and caudal orbitofrontal and dorsolateral
prefrontal cortical regions in subjects with major depres-
sion as compared to psychiatrically normal controls.
Results: Depressed subjects had decreases in cortical
thickness, neuronal sizes, and neuronal and glial densities
in the upper (II–IV) cortical layers of the rostral orbito-
frontal region. In the caudal orbitofrontal cortex in
depressed subjects, there were prominent reductions in
glial densities in the lower (V–VI) cortical layers that were
accompanied by small but significant decreases in neuro-
nal sizes. In the dorsolateral prefrontal cortex of de-
pressed subjects marked reductions in the density and size
of neurons and glial cells were found in both supra- and
infragranular layers.
Conclusions: These results reveal that major depression
can be distinguished by specific histopathology of both
neurons and glial cells in the prefrontal cortex. Our data
will contribute to the interpretation of neuroimaging
findings and identification of dysfunctional neuronal cir-
cuits in major depression. Biol Psychiatry 1999;45:
1085–1098 © 1999 Society of Biological Psychiatry
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*See accompanying Editorial, in this issue.
Introduction
Although depressive illnesses can be serious, and evenlead to suicide, nearly 80 percent of people suffering
from depression can be treated successfully with medica-
tion, psychotherapy, or a combination of both. Pharmaco-
logic, biochemical and neuroanatomical studies are begin-
ning to establish that depressive disorders are brain
diseases with unique histopathological features. Profuse
neurochemical research suggests that the disruption of
monoaminergic neurotransmitter pathways may be critical
in the pathophysiology of major depressive disorder
(MDD). In particular, the serotonin and norepinephrine
systems have been implicated, because nearly all clinically
effective antidepressant medications affect these neuro-
transmitters (Heninger and Charney 1987; Hollister and
Claghorn 1993).
In contrast to the neurochemical literature, there are no
systematic histopathological studies of neurons and glia on
major depression or other mood disorders. Such studies
may be highly relevant because reports in depressed
patients and suicide victims reveal changes in monoamine
receptors and transporters and related second messenger
systems (Arango et al 1995; Biver et al 1997; Klimek et al
1997; Ordway et al 1994; Pacheco et al 1996; Stockmeier
et al 1998) suggesting parallel cellular changes in the
cortical projection areas of monoaminergic neurons. The
prefrontal cortex is a particularly good candidate for a site
of cellular pathology, because this region is an important
target of extensive monoamine projections originating in
the brainstem nuclei including the dorsal raphe, locus
coeruleus and ventral tegmental area. Evidence for histo-
pathology of glia in the subgenual region of the prefrontal
cortex in major depression was recently reported by O¨ ngu¨r
et al. (1998).
Interest in the long overlooked morphopathology of
mood disorders has recently been kindled with the emer-
gence of in vivo brain-imaging techniques. Although the
results of neuroimaging studies are sometimes conflicting,
the majority of such reports have implicated the prefrontal
cortex as a site of functional and structural abnormalities
in mood disorders (for review see Rajkowska 1997). In
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Table 1. Characteristics of Subjects
Control
Age/Gender/
Race PMI A-10
T F
A-47 A-9
Cause of
Death Medication Toxicology
Drugs/
Alcoha
Family
Historyb
CL-1 23/F/C 11.0 22.7 22.7 22.7 Ac levonorgestril implant Clean NA NA
CL-2 24/M/AAm 15.0 15.4 36.5 24.1 H NA Clean NA NA
CL-3 27/F/C 15.0 20.5 21.5 20.5 N Enalapril, Metoprolol,
captopril, lopressor
Clean NA NA
CL-4 30/F/C 9.0 8.9 31.6 19.4 N NA Clean NA NA
CY-5 33/M/C 16.0 13.5 13.5 13.5 N NA NA NA NA
CY-6 43/F/C 8.0 N/A N/A N/A N NA NA NA NA
CL-7 46/F/C 27.0 13.2 13.2 25.5 H maxitrol? Clean NA NA
CL-8 47/M/C 17.0 7.1 7.1 6.8 N famotidine Clean None AA
CY-9 47/M/C 12.0 7.5 7.5 7.5 N NA NA NA NA
CL-10 58/M/C 21.5 8.8 35.0 5.0 N digoxin, lanoxin EtOH-gastric None AA,D
CY-11 71/F/C 24.0 5.5 5.5 5.5 N NA NA NA NA
CL-12c 71/M/C 24.0 8.8 24.0 5.0 N NA Clean AD AA
Average 43.3 16.0 12.3 19.4 15.0
Major
Depression
Age/Gender/
Race PMI A-10
T F
A-47 A-9
Cause of
Death Medication Toxicology
Drugs/
Alcoha
Family
Historyb
Duration of
Depr. (years)d
CL-13 34/F/C 27.0 10.8 10.8 10.8 S Trazodonee, alprazolam,
risperidone, Amoxicillin,
Valproic acid, nitrofurantoin
CO, EtOH-blood, alprazolam NA NA 20
CL-14c 30/M/AAm 18.0 9.8 9.8 6.7 S NA EtOH-blood AA AD, MD, S, SA 3
CL-15f 40/F/C 25.0 14.0 14.0 14.0 N1Ac Temazepam, Fluoxetine,
Hydrocodone, etodolac
Morphine, codeine,
hydrocodone, diphenhydramine
DA AD, D 5
CL-16 42/F/C 24.0 2.0 15.5 7.0 S Fluoxetine, Amitrip.,
Paroxetine, Propoxyphene,
Diazepam, Furosemide
Propoxyphene, acetaminophen PS, DA AD 26
CL-17 42/M/C 20.0 14.5 18.3 16.0 S Sertraline Sertraline, diphenhydramine,
EtOH-urine, norsertraline
None MD, SA 0.25
CL-18 46/M/AAm 17.0 11.6 18.9 7.7 H None Clean NA SA 1
CL-19 50/F/C 23.0 23.1 16.9 14.7 S Clomipramine, ranitidine,
fluoxetine & thiothixene
Clean None AD, D 4
CL-20 54/M/C 23.0 6.7 12.2 12.9 Ac Sertraline CO, phenobarbital, phenytoin None AD 3
CL-21 63/F/C 24.0 6.8 12.2 6.8 N Chlorpromazine, Clonazepam,
Amitrip., amantadine
Amitrip., chlorpromazine,
amantadine, lidocaine
PS, DA, AD AD, I 30
CL-22 73/M/C 10.0 11.0 11.0 16.2 S Nortriptyline nortriptyline None None 5
CL-23c 73/F/C 17.0 14.9 20.9 14.9 N lithium, Nortriptyline,
restoril, Clonazepam,
levothyroxine
Clean AD AD, MD, SA 50
CL-24 86/M/C 21.0 5.6 5.6 5.6 S Fluoxetine, Atenolol,
leuprolide acetate,
lupron
Clean None S 20
Average 52.8 20.8 10.9 13.8 11.1
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major depression at least two different regions, the dorso-
lateral prefrontal cortex (dlPFC) and the orbitofrontal-
ventral region have been implicated. For example, patients
with MDD consistently have reduced glucose metabolism
in the left dlPFC (Baxter et al 1989; Bench et al 1993;
Biver et al 1994). Decreased brain metabolism was found
recently in dlPFC as well as in orbitofrontal cortex (ORB)
in patients with a relapse in depression induced by
depletion of tryptophan (Bremner et al 1997). Abnormally
decreased metabolic activity was also localized in the
ventromedial subgenual region of the frontal lobe in MDD
and bipolar disorder (Drevets et al 1997). In contrast,
earlier studies report increased metabolism or blood flow
in orbitofrontal and ventrolateral prefrontal regions in
MDD patients (Biver et al 1994; Buchsbaum et al 1986;
Drevets and Raichle 1992), although blood flow tended to
be lower in subjects with the greatest severity of depres-
sion (Drevets et al 1992). These apparent inconsistencies
found in the orbitofrontal/ventral region indicate either the
existence of different metabolic patterns in specific sub-
areas of this region or imprecise anatomical localization of
the observed changes.
Pathology of cortical cells may be related to the recent
neuroimaging findings in patients with mood disorders. A
7% reduction of the total volume of the frontal lobe was
reported in MDD (Coffey et al 1993) and substantial
39–48% decreases in the subgenual prefrontal gray matter
volume were found in patients with MDD and bipolar
depression (Drevets et al 1997). The specific neuronal and
glial pathology underlying these gross morphological
changes has not been determined to date. The present
study is the first attempt to use state-of-the art morpho-
metric methods to test whether neuronal or glial cell
pathology can be identified in ORB or dlPFC regions. We
also tested whether the pattern of specific cortical pathol-
ogy is similar or different between prefrontal regions as
suggested by the neuroimaging studies.
Methods and Materials
Human Subjects
Human postmortem brain tissues were obtained at autopsies per-
formed at the Cuyahoga County Coroner’s Office in Cleveland, OH.
Retrospective psychiatric assessments were established at Case
Western Reserve University, Cleveland, OH in accordance with
Institutional Review Board policies and written consent was ob-
tained from the next-of-kin. Dr. P.S. Goldman-Rakic (Yale Univer-
sity School of Medicine) generously donated additional tissues from
four control brains originally obtained from the University of
Zagreb, Croatia, by courtesy of Dr. I. Kostovic. In all cases, a
retrospective psychiatric assessment was used for establishing psy-
chiatric histories of decedents based on information obtained from
significant others or first degree family members and medical
records, where available. Information pertaining to both current and
lifetime psychiatric symptoms was gathered using the Schedule for
Affective Disorders and Schizophrenia: Lifetime Versions
(SADS-L) (Spitzer and Endicott 1978), as described by Stockmeier
et al (1998). Diagnoses for major depression syndromes were based
on the criteria reported in the Diagnostic and Statistic Manual of
Mental Disorders-Revised (DSM-III-R) (American Psychiatric As-
sociation 1987). Consensus on diagnosis was derived during a group
meeting of a psychiatrist (H.M. or B.R.) and a clinical psychologist
(J.O.) after all available information had been thoroughly reviewed.
Kelly and Mann (1996) have shown that there is good agreement
between informant-based retrospective psychiatric assessments of
deceased subjects and diagnoses by clinicians treating the same
subjects before their deaths. In addition, information was obtained
about previous hospital medical records, prior medical or substance
abuse problems and toxicology reports. Subjects were excluded
from the study if there was any evidence of head trauma, neurologic
disease or a current psychoactive substance use disorder (within the
last year of life). Brains were used from subjects who were younger
than 73 years of age (except one subject, CL24 who was 86 years
old), had a postmortem delay of less than 27 hours, and had a
fixation time that did not exceed three years. Fixation times for each
block of tissue are listed in Table 1.
Tissue Sampling
Tissues were collected from the left prefrontal regions in the
brains of 12 subjects retrospectively diagnosed with MDD
(nonpsychotic) and 12 psychiatrically normal controls each
matched by age (no more than 9 years difference between the
subjects of each matching pair), gender, race, postmortem delay,
and fixation time (see Table 1). Morphometric parameters
(cortical thickness, cell density and cell size) were collected from
two orbitofrontal regions, rostral (rORB) and caudal orbitofrontal
(cORB) cortex and from the dorsolateral prefrontal cortex
(dlPFC; Brodmann’s area 9) (Figure 1). In addition, in the middle
orbitofrontal cortex only cortical thickness was measured. The
human orbitofrontal cortex has been subdivided in our recent
cytoarchitectonic study into several discrete cortical regions
based on differences in cellular architecture (Rajkowska et al
1998a). The most rostral subdivision of the orbitofrontal cortex is
located on the lower bank of the frontomarginal sulcus, possesses
mixed cytoarchitectonic features of Brodmann’s area 10 and area
Table 1. Continued
A, area; AA, alcohol abuse; AAm, African American; AD, alcohol dependence; Ac,
accident; C, Caucasian; D, drug abuse; DA, drug addiction; H, homicide; MD,
major depression; N, natural; PMI, postmortem interval (hours)—defined as the
time between death and the beginning of the formalin-fixation process; PS,
polysubstance abuse; S, suicide; SA, suicide attempt; TF, time in formalin
(months); NA, not available; I, institutionalized; EtOH, ethanol; Amitrip., amitrip-
tyline.
CL, cases obtained from CWRU, Cleveland, OH.
CY, cases from the collection of Dr. P.S. Goldman-Rakic.
aDefined as psychoactive substance use disorder.
bExtended and immediate family.
cThe two subjects with MDD previously met diagnostic criteria for alcohol
abuse at 2 and 8 years prior to death.
dThe duration of illness covers the time between the first display (and not
necessarily diagnosis) of symptoms of a depressive illness and the date of death.
eCapitalized drugs were prescribed in last month of life.
fRecurrent MD, in full remission.
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47, and was designated as transitional area 10-47 (Figure 1). The
middle orbitofrontal cortex covers the medial wall of the orbital
sulcus and constitutes area 472. The caudal orbitofrontal cortex
covers the lateral wall of the orbitofrontal sulcus, constitutes the
fourth subdivision of Brodmann’s area 47 and is called area 474.
The precise location and extent of dorsolateral prefrontal area 9
has been described previously based on quantitative cytoarchi-
tectonic criteria (Rajkowska and Goldman-Rakic 1995a, b).
Blocks of tissue (3 3 3 cm) sampled from each of the three left
prefrontal regions were embedded in celloidin, cut into 40 mm
thick coronal sections and stained for Nissl substance. In each
region selected for counting, three cortical probes spanning the
entire gray matter were evenly spaced at 800 mm intervals
representing different rostra-caudal levels of the areas of interest.
3-D Cell Counting
Computer-assisted image analysis with 3-dimensional cell counting
capabilities was used to estimate neuronal and glial cell parameters
(Williams 1989; Williams and Rakic 1988). This system is based on
the optical disector method (Gundersen 1986) and allows for the
estimation of the number of cells independent of cell shape.
Neuronal and glial cell densities are expressed as number of
cells/(mm3 3 1023), cell sizes are calculated as an equivalent
diameter-circle, i.e., (4 3 area)/circumference, of the soma size
(corresponding in the case of Nissl stained glial cells to glial nuclei),
and cortical thickness is measured as the distance between the
overlying pia and underlying white matter. Neurons were divided
into 4 classes according to their size. The range of sizes included in
each class was determined for each layer using the mean (M) and
the standard deviation (]) of the control cases as follows: small
(smaller than M-1]), medium (M-1] to M), large (M to M 1 1]) and
extra large (larger than M 1 1]) (for further details see Rajkowska,
1998b). The morphometric parameters were measured in three
cortical probes sampled as mentioned above. Each probe consisted
of an uninterrupted series of three-dimensional counting boxes
(90 3 60 3 25 mm), optically defined by the computer software.
These boxes spanned the entire depth of the cortex from the
overlying pial surface to the underlying white matter (Figure 1, for
further details on the method, see Rajkowska et al 1998b; Selemon
et al 1995). This sampling method allowed us to measure 4000–
7000 neurons per given area per group and 7000–12000 glial cells
per area/per group, for a total of 33,407 neurons and 58,320 glial
cells measured for the study. All brains used for the study were
coded and counted by two independent researchers (G.R. and J.W.
or J.W. and J.J.M.H.) who were unaware of the diagnoses of the
subjects.
Statistical Analyses
Three separate statistical analyses were conducted. 1) The mean
values from four morphometric parameters (neuronal density,
glial density, cortical thickness and mean cell soma size) mea-
sured across all cortical layers and obtained from the three
cortical probes were compared between the depressed and
control groups for each cortical region separately using single
factor (disease) analyses of variance (ANOVA, p , .05); 2)
laminar differences between groups in each of the above men-
tioned parameters (analyzed separately), for each of the cortical
region were analyzed using a repeated measures (six cortical
layers or five sublayers) ANOVA followed by selected contrast
analyses (p , .05; Systat 5.2.1); 3) differences between the
groups in the density of different cell-size classes (small,
medium, large and extra large) analyzed separately for neuronal
and glial cells were compared by a repeated measures (cell-size
classes) ANOVA followed by selected contrast analyses (p ,
.05). In addition, multiple correlation analysis was used to
examine the influence of age, gender, postmortem delay, storage
time in formalin, and duration of illness on cortical thickness,
neuronal and glial densities, and soma sizes (p , .01). In
addition, Pearson correlation matrixes were used to establish the
relationship between neuronal and glial size and the density of
size classes for each cortical layer and between layers.
Figure 1. Localization of the three prefrontal regions from which
postmortem tissues were sampled for the study. (A) Photograph of
the lateral view of the left cerebral hemisphere from a healthy
control. (B) Camera lucida drawings of representative coronal
sections taken from each of the three studied regions. Black squares
indicate cortical sites in orbitofrontal and dorsolateral prefrontal
regions where measurements were taken. Abbreviations: rORB,
rostral ORB: rostral orbitofrontal region; cORB, caudal ORB:
caudal orbitofrontal region; dlPFC, dorsolateral PFC: dorsolateral
prefrontal cortical region; FMs: fronto-marginal sulcus; SFs: supe-
rior frontal sulcus; ORBs: orbitofrontal sulcus.
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Results
Rostral Orbitofrontal Cortex (area 10–47)
Our morphometric analyses in subjects with MDD showed
that the overall cortical thickness of the rORB was reduced
by 12% (F[1,22] 5 10.681, p 5 .004) as compared to normal
controls (Figure 2A). These reductions in thickness were
accompanied by smaller sizes of neuronal cell bodies (Figure
3). Laminar analysis of mean neuronal sizes and densities in
each of the six cortical layers revealed reductions in mean
neuronal size in supragranular layers (II-IIIc) of rORB in
subjects with MDD (Table 2). The greatest reduction (9%) in
mean neuronal size (F[1,22] 5 23.598, p , .001) occurred in
layer II (Figure 3). In addition, in this layer, and in layers III
and IV, the densities of the largest neurons (belonging to the
“large” or “extra-large” size classes) were significantly re-
duced by 20–60% (Table 2). Accompanying 30–70% sig-
nificant increases in the densities of small neurons were
found only in layer III (Table 2).
There was a trend for a reduction in the overall glial
density in rORB of subjects with MDD as compared to
controls, but these changes did not reach statistical signif-
icance (F[1,22] 5 1.974, p 5 0.17; Figure 4C). Laminar
analysis of size-dependent glial densities revealed signif-
icant decreases in MDD as compared to control subjects.
The density of medium-sized and large glial cells was
significantly reduced by 30% in layers IIIa and IV,
respectively, in MDD (Table 2).
Caudal Orbitofrontal Cortex (area 474)
Unlike the rORB, the cORB revealed only mild (5%) and
nonsignificant reductions in cortical thickness in MDD as
compared to controls (Figure 2C). There was a significant
reduction in mean neuronal size in layer II (6%, p 5 .035),
although this reduction was less prominent than in rORB.
In addition, layers IIIa and Va exhibited significantly
lower densities of large-size neurons in MDD (Table 3).
Glial cell density and size were prominently different in
cORB in MDD as compared to controls. Significant 15%
decreases in overall (F[1,14 ]5 7.645, p 5 .015) and
laminar (layers IIIc–VI) glial cell densities were evident in
the diseased group (Figure 4B). These glial changes in
Figure 2. Plots showing the individual val-
ues of cortical thickness (measured as a
distance across layers I–VI) measurements in
four regions of the prefrontal cortex from
control and depressed subjects. Note that
there was a significant difference in cortical
thickness between control and depressed
groups in rostral orbitofrontal (n 5 12 for
each group) (A) and middle orbitofrontal
cortex (n 5 8 for each group) (B), nonsignif-
icant trend in the caudal orbitofrontal cortex
(n 5 9 for each group) (C), whereas no
difference was found in the dorsolateral pre-
frontal cortex (n 5 12 for each group) (D).
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MDD were accompanied by a reduction in the density of
large and medium-size glial cell nuclei predominantly in
infragranular layers V and VI (Table 3, Figure 4E).
Dorsolateral Prefrontal Cortex (area 9)
The cortical thickness of the dlPFC was nearly the same in
both diseased and control groups (Figure 2D), however,
there were differences evident in cell density and size
between the groups. In the dlPFC, as in orbitofrontal
regions, we found significant reductions in neuronal sizes
in specific cortical layers in MDD. The mean size of
neuronal cell bodies was decreased in MDD by 5%
(F[1,21] 5 4.838, p 5 .039) in supragranular layer III and
by 7% (F[1,21] 5 5.666, p 5 .027) in infragranular layer
VI (Table 4). In those layers as well as in layer II the
density of the largest neurons in MDD was significantly
reduced by 20–60% below control values with an accom-
panying 40% increase in the density of the smallest
neurons (Table 4, Figure 3).
The neuronal changes in dlPFC in MDD were associ-
ated with marked 20–30% reductions in the mean glial
density cells in layers III and V as well as the density of
medium- and large-size glial cells in those layers (Table 4,
Figure 4A,D). Interestingly, in layer III, glial cells of the
Figure 3. Changes in neuro-
nal size and size-dependent
density in layer II of rostral
orbitofrontal cortex in subjects
with MDD as compared to
matched healthy control (both
were Caucasian females, 73
and 71 years old, respectively,
with postmortem delay less
than 17 hours and fixation
time less than 10 months).
Photomicrograph of the cell
composition across the six
cortical layers in rORB (Up-
per left). Expanded print-outs
of cortical layers with neuro-
nal cell bodies represented by
equivalent diameter circles
with the area measured for the
individual neuron in its equa-
torial plane (right panel). Note
that in the depressed subject
neuronal sizes are smaller in
layers II and III than in con-
trol. Note especially dramatic
increases in the density of
small neurons in layer II asso-
ciated with significant reduc-
tions in the density of the larg-
est neurons of this layer (also
see Table 2). This relationship
is further illustrated on the
histogram of the cell size dis-
tribution created for 12 MDD
and 12 control subjects (lower
left).
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size-class with the largest nuclei also exhibited significant
60–120% (F[1,23] 5 8.368, p 5 .008) increases in density
in MDD.
Correlation Analysis
Decreases in cortical thickness, neuronal size and neuronal
and glial density of specific size classes revealed by our study
of MDD were not dependent on age, race, postmortem delay
or storage time in formalin (Figure 5C–F). There was a trend
toward negative correlation with duration of illness; however,
values did not reach the level of significance. Mean neuronal
size in layers II, III and IV of rORB in MDD however, was
positively correlated with the density of extra large (r 5 .683,
p , .001 for layer II; r 5 .891, p , .001 for layer III; r 5
.670, p , .001 for layer IV) and large (r 5 .500, p 5 .003 for
layer II; r 5 .611, p 5 .002 for layer IV) neurons in
corresponding layers and negatively correlated with the
density of small (r 5 2.851, p , .001 for layer III; r 5
2.758, p , .001 for layer IV) and medium-sized (r 5 2.502,
Table 2. Analysis of layer-specific soma size classes, mean densities, and mean soma sizes of neurons and glia in the rORB in
brains of control and depressed subjects
Neurons P Values
Layers
Control Depressed Mean
Neuron
Density
Mean
Neuron
Size
Size Class Densities
Mean
Neuron
Density
Mean
Neuron
Size
Mean
Neuron
Density
Mean
Neuron
Size
Sm Med Lg XLrg
P P P P P P
rORB Avg s Avg s Avg s Avg s P P P P P P
I 24 8 9.2 0.6 22 7 9.0 0.6
II 119 16 11.2 0.6 119 15 10.2 0.5 0.0002 0.0122 0.0002
III 63 6 14.3 0.9 60 5 13.5 0.7 0.0152 0.0511 0.0112 0.0432
IIIa 77 10 13.7 1.3 71 8 12.7 0.8 0.0292 0.0172
IIIb 53 5 14.6 0.7 51 5 13.9 0.7 0.0242 0.0122
IIIc 71 15 14.4 0.9 69 10 13.5 0.9 0.0192 0.0091 (0.054)2
IV 117 18 11.1 0.5 109 18 10.8 0.5 0.0092
V 60 9 13.7 0.8 59 9 13.7 1.1
Va 71 13 13.7 0.9 70 13 14.0 1.4
Vb 50 7 13.8 1.1 47 9 13.6 0.9
VI 43 6 13.9 1.2 42 7 13.2 0.8
All Layers 62 5 12.9 0.6 61 6 12.3 0.5 0.0152 0.0351 0.0282 (0.054)2
Glia P Values
Control Depressed Mean
Glia
Density
Mean
Glia
Size
Size Class Densities
Layers
Mean
Glia
Density
Mean
Glia
Size
Mean
Glia
Density
Mean
Glia
Size
Sm Med Lg XLrg
P P P P P P
Avg s Avg s Avg s Avg s P P P P P P
I 97 24 5.1 0.2 88 23 5.3 0.4
II 96 32 5.3 0.2 76 22 5.5 0.3
III 96 18 5.2 0.2 84 19 5.3 0.3
IIIa 89 16 5.3 0.1 78 22 5.4 0.3 0.0402
IIIb 92 19 5.2 0.2 83 19 5.3 0.3
IIIc 103 20 5.2 0.3 88 21 5.3 0.2
IV 109 17 5.1 0.2 95 23 5.2 0.3 0.0042
V 107 21 5.2 0.3 94 25 5.2 0.2
Va 102 24 5.2 0.3 86 22 5.3 0.3
Vb 113 22 5.2 0.3 101 31 5.2 0.2
VI 140 22 5.2 0.2 141 22 5.2 0.2
All Layers 110 17 5.2 0.2 100 17 5.3 0.2
ANOVA significant p-values (bold) and near significant values, 0.05 , p , 0.06 (parentheses) are indicated. Arrows indicate the direction of change. Avg: mean values
for individual cortical layers and sublayers and all layers combined; s: standard deviations. Mean cell densities are described in # cells/(mm3 3 1023) mm. Mean cell sizes
are described in 4 3 (Area/Circumference) mm. Size classes of neurons are described as small (Range: 4.3–11.4 mm), medium (7.1–15.7 mm), large (8.6–20.4 mm), and
extra-large (10.2–35.5 mm). Size classes of glia are described as small (Range: 2.2–4.7 mm), medium (4.3–5.3 mm), large (5.0–6.1 mm), and extra-large (5.6–13.0 mm).
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p 5 .012 for layer III; r 5 2.708, p , .001 for layer IV)
neurons in those layers (Figure 5A,B). Furthermore, the
density of extra large neurons was negatively correlated with
the density of small (r 5 2.665, p , .001) and medium-sized
(r 5 2.615, p 5 .001) neurons in layer III of rORB. Thus, in
MDD the smaller the mean size of the cell body, the lower
the density of large and extra large neurons and the higher the
density of small and medium-sized neurons.
In cORB and in dlPFC (both located caudally to rORB in
the frontal lobe) the density of large or extra large neurons in
MDD was also negatively correlated with the density of
small neurons in layers II (r 5 2.692, p 5 .002) and VI (r 5
2.608, p 5 .013) of cORB and in layer III of dlPFC (r 5
2.586, p 5 .003). Moreover, the density of extra large
neurons in layer II of cORB was positively correlated with
the density of extra large glial cells in this layer (r 5 .631,
p 5 .009) and with the density of large glial cells in layer I
(r 5 2.645, p 5 .007). Finally, in MDD the densities of
different size-classes of glial cells were correlated within a
given cortical layer or between different layers. For example,
the density of small glial cells was positively correlated with
the density of medium-sized glia in layer III of rORB (r 5
.550, p 5 .005) whereas small glial cell density was nega-
tively correlated with the density of large (r 5 2.656, p 5
.006) and very large glial cells in layers II (r 5 2.819, p ,
.001) and III (r 5 2.601, p 5 .014) of cORB. Densities of
large glial cells were also positively correlated between layers
V and VI of cORB (r 5 736, p 5 .001); densities of extra
large glia were correlated between layers III and IV of rORB
(r 5 689, p , .001) and densities of small glia were
correlated between layers III and IV of rORB (r 5 864, p ,
.001).
Summary of Cellular Changes in MDD
The results described above indicate that both neurons
and glial cells are involved in the histopathology of
major depression in prefrontal cortex. The degree of
involvement of neurons and glia in the pathology differs
among prefrontal regions and specific cortical layers.
Neuronal changes were most prominent in the rORB
region whereas changes in glial cells were most striking
in more caudally located regions of the prefrontal
cortex, the cORB and dlPFC (compare Tables 2, 3 and
4). Reductions in neuronal size and density found in the
rORB in MDD were restricted to supragranular layers
Figure 4. Plots representing
individual values of the den-
sity of glial cells in layer V in
three different regions of the
prefrontal cortex of control
and depressed subjects (A–
C). Note that for areas 9 (A)
and 474 (B) the density of
glial cells is significantly
smaller in depressed subjects
compared to controls. The
histograms in the bottom
show the distribution of the
density of glial cells somata
(in our Nissl stained material
corresponding to glial nuclei)
into various defined size
classes in areas 9 (D) and 474
(E). Note that in these areas
the density of medium- and
large-size glial cells is signif-
icantly decreased in de-
pressed subjects compared to
controls whereas density of
glial cells with the largest
nuclei is significantly in-
creased in area 9.
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and layer IV whereas decreases in glial cell density in
MDD were found predominantly in infragranular layers
of the cORB. Moreover, reductions in neuronal and
glial cell density and in neuronal cell size were often
found to be correlated in the same cortical layer.
Significant decreases in cortical thickness in MDD were
observed only in the most rostral prefrontal regions,
involving rORB and middle orbitofrontal cortex (see
Figure 2A, B).
Discussion
Cellular Changes
The densities of the largest neurons were consistently
reduced in the rORB, dlPFC and, to a lesser degree, in the
cORB of postmortem brains from subjects diagnosed with
major depressive disorder. These decreases in densities of
the largest neurons in specific layers of the rORB and
dlPFC were accompanied by parallel increases in the
Table 3. Analysis of layer-specific soma size classes, mean densities, and mean soma sizes of neurons and glia in the cORB in
brains of control and depressed subjects
Neurons P Values
Layers
Control Depressed Mean
Neuron
Density
Mean
Neuron
Size
Size Class Densities
Mean
Neuron
Density
Mean
Neuron
Size
Mean
Neuron
Density
Mean
Neuron
Size
Sm Med Lg XLrg
P P P P P P
cORB Avg s Avg s Avg s Avg s P P P P P P
I 21 9 8.7 0.6 17 6 8.4 0.5
II 111 11 10.1 0.5 121 24 9.5 0.5 0.0352
III 60 4 14.3 0.6 59 6 13.7 0.7
IIIa 83 14 12.6 0.9 76 9 11.9 0.8 0.0132
IIIb 52 5 14.4 0.9 51 8 13.9 0.7
IIIc 61 5 15.3 0.8 59 7 14.8 1.2
IV 108 4 10.6 0.5 104 17 10.5 0.4
V 56 7 13.6 1.0 54 6 13.6 0.6
Va 73 12 13.6 1.2 67 12 13.7 0.8 0.0422
Vb 42 9 13.7 1.0 42 7 13.4 0.9
VI 37 5 13.5 1.2 40 4 13.3 1.0
All Layers 57 4 12.6 0.6 57 5 12.2 0.5
Glia P Values
Control Depressed Mean
Glia
Density
Mean
Glia
Size
Size Class Densities
Layers
Mean
Glia
Density
Mean
Glia
Size
Mean
Glia
Density
Mean
Glia
Size
Sm Med Lg XLrg
P P P P P P
Avg s Avg s Avg s Avg s P P P P P P
I 98 12 5.0 0.3 86 15 5.0 0.3 0.0342
II 73 15 5.2 0.3 72 15 5.2 0.4
III 92 11 5.1 0.2 81 13 5.1 0.2
IIIa 74 7 5.1 0.2 67 13 5.2 0.3
IIIb 87 13 5.1 0.2 79 16 5.2 0.3
IIIc 108 17 5.0 0.3 91 17 5.1 0.2 0.0462
IV 110 13 5.0 0.2 90 19 5.0 0.3 0.0192
V 110 11 5.0 0.2 89 12 5.1 0.3 0.0062 0.0132
Va 105 11 5.1 0.2 86 17 5.1 0.3 0.0472 0.0382
Vb 115 16 5.0 0.2 94 13 5.0 0.2 0.0152 0.0032
VI 132 18 5.2 0.2 117 10 5.1 0.2 0.0432 0.0332
All Layers 105 7 5.1 0.2 91 14 5.1 0.2 0.0152 0.0422
ANOVA significant p-values are indicated in bold. Arrows indicate the direction of change. Avg: mean values for individual cortical layers and sublayers and all layers
combined; s: standard deviations. Mean cell densities are described in # cells/(mm3 3 1023) mm. Mean cell sizes are described in 4 3 (Area/Circumference) mm. Size classes
of neurons are described as small (Range: 4.3–11.4 mm), medium (7.1–15.7 mm), large (8.6–20.4 mm), and extra-large (10.2–35.5 mm). Size classes of glia are described
as small (Range: 2.2–4.7 mm), medium (4.3–5.3 mm), large (5.0–6.1 mm), and extra-large (5.6–13.0 mm).
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density of small neurons and were correlated with reduc-
tions in mean neuronal sizes. The latter observation
suggests that neuronal shrinkage or a developmental defi-
ciency rather than neuronal loss account for the overall
smaller neuronal sizes in those cortical layers. If neuronal
loss had occurred the density of large neurons would have
been decreased without associated increases in the density
of small neurons, as has been recently demonstrated in
Huntington’s disease, a well-characterized neurodegenera-
tive disorder (Rajkowska et al 1998b).
The changes in densities of large and extra large neurons in
MDD were positively correlated with changes in glial cell
densities. A lower density of the large neurons was accom-
panied by a lower density of glial cells in specific cortical
layers. In the dlPFC, the lower overall glial density was
accompanied by marked increases in the density of the
Table 4. Analysis of layer-specific soma size classes, mean densities, and mean soma sizes of neurons and glia in the dlPFC in
brains of control and depressed subjects
Neurons P Values
Layers
Control Depressed Mean
Neuron
Density
Mean
Neuron
Size
Size Class Densities
Mean
Neuron
Density
Mean
Neuron
Size
Mean
Neuron
Density
Mean
Neuron
Size
Sm Med Lg XLrg
P P P P P P
dlPFC Avg s Avg s Avg s Avg s P P P P P P
I 15 4 8.7 0.6 13 4 8.5 0.7
II 106 22 10.9 0.9 105 15 10.3 1.0 0.0432
III 56 8 14.9 0.9 54 5 14.3 0.7 0.0392 0.0202 0.0422
IIIa 71 13 13.4 1.3 72 8 12.8 0.7
IIIb 50 9 15.0 0.8 47 4 14.5 0.5 (0.051)
IIIc 58 13 15.9 1.1 59 8 15.1 1.4 0.0501
IV 106 20 11.3 0.9 103 15 11.0 0.5
V 53 7 14.6 1.2 52 7 14.3 0.7
Va 65 10 14.9 1.5 65 7 14.7 0.8
Vb 42 8 14.5 1.3 42 10 13.9 0.8
VI 36 9 14.5 1.4 38 5 13.5 0.7 0.0272 0.0331 0.0332
All Layers 54 9 13.4 0.9 53 6 12.8 0.6 0.0432 0.0122
Glia P Values
Control Depressed Mean
Glia
Density
Mean
Glia
Size
Size Class Densities
Layers
Mean
Glia
Density
Mean
Glia
Size
Mean
Glia
Density
Mean
Glia
Size
Sm Med Lg XLrg
P P P P P P
Avg s Avg s Avg s Avg s P P P P P P
I 81 21 4.9 0.2 74 15 5.1 0.4
II 71 19 5.2 0.3 70 17 5.4 0.4
III 91 14 5.1 0.2 82 11 5.3 0.3 0.0142 0.0291
IIIa 76 19 5.1 0.2 68 17 5.4 0.4 0.0121 0.0102 0.0081
IIIb 90 13 5.1 0.2 80 9 5.3 0.3 0.0172 0.0172 (0.057)1
IIIc 103 19 5.1 0.2 93 15 5.3 0.3 0.0271
IV 107 22 5.1 0.3 94 15 5.3 0.3
V 103 13 5.1 0.2 92 11 5.3 0.3 0.0422 0.0502 0.0352
Va 107 19 5.2 0.2 87 12 5.3 0.4 0.0052 0.0232 0.0262
Vb 102 18 5.1 0.2 93 16 5.2 0.3
VI 132 21 5.2 0.2 128 14 5.3 0.3
All Layers 100 13 5.1 0.2 92 9 5.3 0.3 0.0292 (0.054)1
ANOVA significant p-values (bold) and near significant values, 0.05 , p , 0.06, (parentheses) are indicated. Arrows indicate the direction of change. Avg: mean
values for individual cortical layers and sublayers and all layers combined; s: standard deviations. Mean cell densities are described in # cells/(mm3 3 1023) mm.
Mean cell sizes are described in 4 3 (Area/Circumference) mm. Size classes of neurons are described as small (Range: 4.3–11.4 mm), medium (7.1–15.7 mm), large
(8.6 –20.4 mm), and extra-large (10.2–35.5 mm). Size classes of glia are described as small (Range: 2.2– 4.7 mm), medium (4.3–5.3 mm), large (5.0 – 6.1 mm), and
extra-large (5.6 –13.0 mm).
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largest glial nuclei suggesting enlargement of the glial cells.
Similar increases in glial nuclear sizes are reported in the
same prefrontal region for Huntington’s disease (Rajkowska
et al 1998b). In Huntington’s disease however, enlargement
of glial cells is associated with marked increases in glial cell
densities (Selemon et al 1995). Glial enlargement and prolif-
eration in neurodegenerative brain disorders seem to occur in
response to neuronal injury. Our present finding of a decrease
rather than an increase in glial density in MDD seems unique
to mood disorders and has not been observed in previous
morphometric studies of the prefrontal cortex in subjects with
schizophrenia or Huntington’s disease (Rajkowska et al
1998b; Selemon et al 1995). Recently, we detected compa-
rably lower glial densities in brain tissues from subjects with
bipolar (manic-depressive) illness (Rajkowska et al 1997).
Our observations on glial changes in both types of mood
disorders, MDD and bipolar illness, have been independently
confirmed (O¨ ngu¨r et al 1998).
Implications for the Link Between Cell Pathology
and Neuroimaging
The neuronal and glial changes described here suggest that
different regions of the prefrontal cortex might contribute
differentially to the histopathology of MDD. Significant
decreases in cortical thickness and neuronal sizes in rORB
in MDD suggest that atrophy of cortical neurons may
account for the reduced volume of cortical gray matter and
be related to the decreased metabolic activity reported for
this region in neuroimaging studies on depressed patients
(Bremner et al 1997). Likewise, the marked reductions in
glial densities and moderate reductions in neuronal size
Figure 5. Plots of correlation analysis for several relevant parameters related to the brain samples used in the present study in specific
layers, where significant changes were found. Plots A and B (both from layer II in rORB) show that the density of extra large neurons
is positively correlated with mean neuronal soma size (A) and with the density of medium-sized glia (B). In plot C, we illustrate the
absence of correlation between density of glial cells and postmortem interval in layer V of cORB, where we found the greatest changes
in glial density. Plots D, E, F (all from layer II of rORB) show that the postmortem interval (PMI) (D), the time in fixative (E), and
the age of the subjects (F) are not significantly correlated with mean neuronal soma size.
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(without significant decreases in cortical thickness) found
in the left cORB and dlPFC may be related to the altered
metabolism reported in these regions. Glial cells are
involved in the active processing of glucose and are
reported as the primary sites of glucose uptake and
phosphorylation during neuronal activity (Tsacopoulos
and Magistretti 1996).
Our histopathological data therefore indicate that the two
orbital regions and the dlPFC exhibit cytoarchitectural alter-
ations involving both neurons and glial cells. The differences
that we found between rostral (rORB) and caudal (cORB and
dlPFC) prefrontal regions in MDD refer to the degree of
neuronal or glial contribution to putative pathology of spe-
cific cortical layers in these prefrontal regions. Therefore, the
present data suggest the existence of a rostral-to-caudal rather
than a dorsal-to-ventral pattern of morphometric changes in
the prefrontal cortex of subjects with MDD. This observation
is of interest because previous computerized tomographic
scans of brain lesions in depressed patients have shown that
lesions in more rostral regions of the frontal pole are
positively correlated with the occurrence of more severe
depression (Robinson and Szetela 1981). It is tempting to
speculate that the duration of depression may correlate with
the degree and severity of the rostral frontal damage. In our
cases a decrease in the size of neuronal somata in rORB
showed a nonsignificant trend toward a negative correlation
with the duration of depression. A challenging interpretation
of the results that cannot be ruled out is that there is a
temporal sequence in the appearance of histopathological
changes in the frontal lobe that will spread through dysfunc-
tional connections to neighboring cortical areas.
Laminar-Specific Cell Pathology and
Neurotransmitter Systems
The reductions in neuronal sizes described here in MDD
were restricted to upper cortical layers (II–IV) in the rORB
although in cORB and dlPFC other layers were also
affected. The differential involvement of cortical layers
suggests that specific populations of cortical neurons
might be related to the histopathology of prefrontal cortex
in MDD. Primate studies revealed that neurons of layers
II–IV are involved in the establishment of connections
with other cortical regions and are targets for subcortical
inputs (Schwartz and Goldman-Rakic 1984; Selemon and
Goldman-Rakic 1988). Recent findings in monkey pre-
frontal cortex show that serotonergic axons terminate
predominantly on nonpyramidal neurons of layers I to IV
(Lewis 1992; Smiley and Goldman-Rakic 1996). More-
over, layer II, where neuronal diminution was especially
pronounced can be distinguished from other cortical layers
of normal human prefrontal cortex by a particularly dense
lamina of serotonergic receptors (Arango et al 1995; Pazos
et al 1987). Finally, the reports of an upregulation in
serotonin-1A and serotonin-2A receptors and downregu-
lation of serotonin transporters predominantly in layer II
and in layers III–IV of the ventrolateral prefrontal cortex
in (presumably depressed) suicide victims (Arango et al
1990; Arango et al 1995) suggest a neuropharmacological
link to altered neuronal size in upper layers of this region.
These morphometric and pharmacologic observations im-
ply that serotonergic axons, and the receptors and cortical
neurons that are recipients of these axons, may be impor-
tant targets of antidepressant medications.
In cORB and dlPFC, in contrast to rORB, laminar-specific
reductions in neuronal sizes and glial densities were found in
the lower portions of layer III and in layers V and VI in
MDD. From primate studies, layers III, V and VI are known
to give rise to glutamatergic pathways descending to various
subcortical structures, including the basal ganglia, that are
involved in control of motor functions (Arikuni and Kubota
1986; Selemon and Goldman-Rakic 1985). It interesting to
speculate that altered functioning in these pathways may be
related to the psychomotor retardation often observed in
depressed patients. Moreover, layer V of the non-human
primates and human prefrontal cortex is the site of colocal-
ization of dopamine-1 and dopamine-2 receptors (Goldman-
Rakic 1998; Goldman-Rakic et al 1990; Joyce et al 1991;
Williams and Goldman-Rakic 1998) further suggesting the
prefrontal involvement of dopaminergic system in the neu-
ropathology of MDD. In addition, neurons of layers V and VI
are recipients of extensive noradrenergic projections (Lewis
and Morrison 1989) coming from the locus coeruleus, that is
known to be involved in the pathology of MDD (Klimek et
al 1997; Ordway et al 1994). Thus, the layer-specific cellular
changes reported here suggest an involvement of many other
neurotransmitter systems in addition to the serotonin system.
Conclusions
The cellular changes described here indicate that both types
of brain cells, neurons and glia, are abnormal in major
depression, and may contribute to pathologic changes in the
prefrontal cortex related to the psychiatric disorder. The
question remains whether depressed patients are genetically
predisposed for the cortical cell changes found in their brains
postmortem and they were born with smaller neurons or less
glia or whether the cellular changes are a consequence of
MDD. Alternatively, those genetically predisposed to the
greatest histopathological alterations may exhibit the most
pernicious psychiatric symptoms. It would be useful to
examine the morphological and metabolic features of pre-
frontal cortex in identical twins discordant for MDD. Inter-
estingly, cortical layers II and III, where we observed the
most profound neuronal and glial changes, are among the last
prefrontal layers to develop; their neurochemical maturation
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and the stabilization of their neuronal elements is prolonged
beyond birth in the human prefrontal cortex (Koenderink et al
1994; Kostovic et al 1988; Mrzljak et al 1992). Of great
relevance to the neurodevelopmental issue is the recent
proton MRS study that found increased levels of cytosolic,
choline-containing compounds in the orbitofrontal cortex of
depressed adolescents (Steingard et al 1998). This study
suggests that abnormal development of the orbitofrontal
cortex may be associated with the early onset of depression.
The pathology of cortical cells in MDD must also be
evaluated taking into consideration that those changes
might be a result of exposure to antidepressant medica-
tions. It remains to be determined whether the morpholog-
ical changes detected postmortem in subjects with MDD
are trait or state dependent, and whether antidepressant
medications have effect on cell morphology. In the present
study, comparable cell pathology was detected even in the
two MDD subjects who were never taking antidepressant
medications. Further behavioral and morphometric studies
on animals treated with antidepressant medications will
shed more light on this crucial issue.
The present report represents the first morphometric
evidence for the involvement of neurons and glial cells in
the histopathology of major depression. These findings
open new insights into the neurobiology of major depres-
sion and suggest it as a brain disease with distinct
histopathological features.
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